Teva Pharmaceutical reported $1.31B in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aspen Pharmacare APN:SJ ZAR 4.58B 1.07B
Cipla CIPLA:IN INR 14.08B 1.05B
Dr.Reddys Laboratories DRRD:IN INR 19.52B 505M
Kalbe Farma Tbk Pt KLBF:IJ IDR 1.25T 90.94B
Richter Gedeon RICHT:HB HUF 77B 21.49B
Sun Pharmaceuticals SUNP:IN INR 30.07B 1.91B
Teva Pharmaceutical TEVA:IT USD 1.31B 245M